FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elizabeth Miller

Research Profile

Living Beings

Geographic Areas

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Emily J Nicoli; Caroline L Trotter; Katherine M E Turner; Pauline Waight; Caroline Colijn; Elizabeth Miller
Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK.
Bruno Pichon; Anne Segonds-Pichon; Mary P E Slack; Pauline A Waight; Nick J Andrews; Shamez N Ladhani; Elizabeth Miller; Robert George
Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.
A J van Hoek; G Amirthalingam; N Andrews; H Campbell; Elizabeth Miller
The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elizabeth Miller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emily J Nicoli; Caroline L Trotter; Katherine M E Turner; Pauline Waight; Caroline Colijn; Elizabeth Miller
Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK.
The Journal of infection 2013;66(6):512-20.
2013: Bruno Pichon; Anne Segonds-Pichon; Mary P E Slack; Pauline A Waight; Nick J Andrews; Shamez N Ladhani; Elizabeth Miller; Robert George
Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.
Journal of clinical microbiology 2013;51(3):820-7.
2013: A J van Hoek; G Amirthalingam; N Andrews; H Campbell; Elizabeth Miller
The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011.
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2013;18(9):.
2013: Elizabeth Miller; John Shneerson; L Stellitano; Julia Stowe; Nick Andrews; Anne Marie Winstone; Chris Verity
Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.
BMJ (Clinical research ed.) 2013;346():f794.
2012: Albert Jan van Hoek; Yoon Hong Choi; Elizabeth Miller; Caroline Trotter; Mark Jit
The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England.
Vaccine 2012;30(50):7205-13.
2012: Albert Jan van Hoek; Pauline Waight; Julia Stowe; Nick Andrews; Peter Gates; Robert George; Elizabeth Miller
The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.
The Journal of infection 2012;65(1):17-24.
2012: Helen Findlow; Jamie Findlow; David Goldblatt; Mary Matheson; Nick Andrews; Lindsey Ashton; Ray Borrow; Anna England; Elizabeth Sheasby; Pauline Waight; Elizabeth Miller
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom.
The Pediatric infectious disease journal 2012;31(6):616-22.
2012: Marc Baguelin; Mark Jit; Elizabeth Miller; William John Edmunds
Health and economic impact of the seasonal influenza vaccination programme in England.
Vaccine 2012;30(23):3459-62.
2012: Albert Jan van Hoek; Pauline Waight; Nick Andrews; Robert George; Elizabeth Miller
Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.
PloS one 2012;7(7):e39150.
2011: Julia Stowe; Suzie Seabroke; Nick Andrews; Phil Bryan; Elizabeth Miller
Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
Vaccine 2011;29(51):9467-72.
2011: Elizabeth Miller; Mary P E Slack; Pauline A Waight; Nicholas J Andrews; Robert C George
Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.
Vaccine 2011;29(49):9127-31.
2011: Elizabeth Miller; Mary Pe Slack; Pauline A Waight; Nicholas J Andrews; Robert C George
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
The Lancet infectious diseases 2011;11(10):760-8.
2011: Elaine Stanford; Pauline Waight; Shamez Ladhani; Elizabeth Miller; Mary Slack; Paul Balmer; Ray Borrow; Robert George; Matthew Helbert
Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal disease.
The Pediatric infectious disease journal 2011;30(6):462-5.
2011: Stefan Flasche; Albert Jan Van Hoek; Elizabeth Sheasby; Pauline Waight; Nick Andrews; Carmen Sheppard; Robert George; Elizabeth Miller
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.
PLoS medicine 2011;8(4):e1001017.
2011: Richard Pebody; Nick Andrews; Pauline Waight; Rashmi Malkani; Christine McCartney; Joanna Ellis; Elizabeth Miller
No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
Vaccine 2011;29(14):2613-8.
2011: Helen Findlow; Ray Borrow; P Hardelid; E Newton; S Frankland; S Naylor; Elizabeth Miller; Edward B Kaczmarski; R C Read
Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults.
Clinical and vaccine immunology : CVI 2011;18(3):424-9.
2011: Elizabeth Miller; Nick Andrews; Pauline Waight; Helen Findlow; Lindsey Ashton; Anna England; Elaine Stanford; Mary Matheson; Jo Southern; Elizabeth Sheasby; David Goldblatt; Ray Borrow
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.
Clinical and vaccine immunology : CVI 2011;18(3):367-72.
2011: Yoon Hong Choi; Nigel Gay; Robert George; Mark Jit; Alessia Melegaro; Nick Andrews; Pauline Waight; Elizabeth Miller
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
PloS one 2011;6(10):e26190.
2011: S Flasche; M Slack; Elizabeth Miller
Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales.
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2011;16(20):19868.
2011: Albert Jan van Hoek; Anthony Underwood; Mark Jit; Elizabeth Miller; W John Edmunds
The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study.
PloS one 2011;6(3):e17030.
2011: Marc Baguelin; Katja Hoschler; Elaine Stanford; Pauline Waight; Pia Hardelid; Nick Andrews; Elizabeth Miller
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.
PloS one 2011;6(2):e17074.
2010: Mark Jit; Deborah Cromer; Marc Baguelin; Julia Stowe; Nick Andrews; Elizabeth Miller
The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.
Vaccine 2010;29(1):115-22.
2010: P Hardelid; N J Andrews; K Hoschler; E Stanford; M Baguelin; Pauline Waight; Maria C Zambon; Elizabeth Miller
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Health technology assessment (Winchester, England) 2010;14(55):115-92.
2010: Jamie Findlow; Ray Borrow; Matthew D Snape; Tom Dawson; Ann Holland; Tessa M John; Anita Evans; Karen L Telford; Ellen Ypma; Daniela Toneatto; Philipp Oster; Elizabeth Miller; Andrew J Pollard
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(10):1127-37.
2010: Nick Andrews; Julia Stowe; Lesley Wise; Elizabeth Miller
Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom.
Vaccine 2010;28(44):7215-20.
2010: Helen Campbell; Nick Andrews; Ray Borrow; Caroline Trotter; Elizabeth Miller
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.
Clinical and vaccine immunology : CVI 2010;17(5):840-7.
2010: David Goldblatt; Jo Southern; Lindsey Ashton; Nick Andrews; Sarah Woodgate; Polly Burbidge; Pauline Waight; Elizabeth Miller
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom.
The Pediatric infectious disease journal 2010;29(5):401-5.
2010: Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
Lancet 2010;375(9720):1100-8.
2010: Caroline L Trotter; Pauline Waight; Nick J Andrews; Mary Slack; Androulla Efstratiou; Robert George; Elizabeth Miller
Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006.
The Journal of infection 2010;60(3):200-8.
2010: Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.
BMC infectious diseases 2010;10():90.
2010: Ray Borrow; Nick Andrews; Helen Findlow; Pauline Waight; Jo Southern; Annette Crowley-Luke; Lorraine Stapley; Anna England; Jamie Findlow; Elizabeth Miller
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
Clinical and vaccine immunology : CVI 2010;17(1):154-9.
2009: David Goldblatt; Jo Southern; Nick Andrews; Lindsey Ashton; Polly Burbidge; Sarah Woodgate; Richard Pebody; Elizabeth Miller
The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(9):1318-25.
2009: Nicholas Kitchin; Joanna Southern; Rhonwen Morris; Ray Borrow; Anne Fiquet; Florence Boisnard; Stéphane Thomas; Elizabeth Miller
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Vaccine 2009;27(37):5096-102.
2009: Norman K Fry; John Duncan; Karen Wagner; Oceanis Tzivra; Nita Doshi; David J Litt; Natasha Crowcroft; Elizabeth Miller; Robert C George; Timothy G Harrison
Role of PCR in the diagnosis of pertussis infection in infants: 5 years' experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007.
Journal of medical microbiology 2009;58(Pt 8):1023-9.
2009: Anthony Nardone; C G Anastassopoulou; Heidi Theeten; B Kriz; I Davidkin; W Thierfelder; Darina O'Flanagan; B Bruzzone; Joël Mossong; H J Boot; D Butur; M Slaciková; M L C Panait; W Hellenbrand; H DE Melker; Z Sobotová; G Icardi; Nick Andrews; Richard Pebody; Pierre Van Damme; G Kafatos; Elizabeth Miller; Angelos Hatzakis
A comparison of hepatitis B seroepidemiology in ten European countries.
Epidemiology and infection 2009;137(7):961-9.
2009: Helen Campbell; Ray Borrow; David Salisbury; Elizabeth Miller
Meningococcal C conjugate vaccine: the experience in England and Wales.
Vaccine 2009;27 Suppl 2():B20-9.
2009: C G Anastassopoulou; G Kafatos; A Nardone; N Andrews; R G Pebody; J Mossong; I Davidkin; D Gelb; F DE Ory; W Thierfelder; V Nemecek; B Bruzzone; D Butur; C Barbara; Z Sobotová; L Jones; A Griskevicius; L M Hesketh; D Cohen; R Vranckx; Athanassios Tsakris; Elizabeth Miller; Angelos Hatzakis
The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries.
Epidemiology and infection 2009;137(4):485-94.
2009: Julia Stowe; Nick Andrews; Brent Taylor; Elizabeth Miller
No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine.
Vaccine 2009;27(9):1422-5.
2009: Jo Southern; Ray Borrow; Nick Andrews; Rhonwen Morris; Pauline Waight; Michael Hudson; Paul Balmer; Helen Findlow; Jamie Findlow; Elizabeth Miller
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.
Clinical and vaccine immunology : CVI 2009;16(2):194-9.
2009: Julia Stowe; Nick Andrews; Lesley Wise; Elizabeth Miller
Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.
American journal of epidemiology 2009;169(3):382-8.
2009: Andrew J Pollard; Amanda Reiner; Tessa John; Elizabeth Sheasby; Matthew Snape; Saul Faust; Andrew Collinson; Adam Finn; Paul T Heath; Elizabeth Miller
Future of flu vaccines. Expediting clinical trials in a pandemic.
BMJ (Clinical research ed.) 2009;339():b4652.
2008: Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.
Clinical and vaccine immunology : CVI 2008;15(11):1694-8.
2008: Ray Borrow; Elaine Stanford; Pauline Waight; Matthew Helbert; Paul Balmer; Rosalind Warrington; Mary Slack; Robert George; Elizabeth Miller
Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease.
Infection and immunity 2008;76(11):5305-9.
2008: Caroline L Trotter; James M Stuart; Robert George; Elizabeth Miller
Increasing hospital admissions for pneumonia, England.
Emerging infectious diseases 2008;14(5):727-33.
2008: Natasha S Crowcroft; M Zambon; Timothy G Harrison; Q Mok; Paul Heath; Elizabeth Miller
Respiratory syncytial virus infection in infants admitted to paediatric intensive care units in London, and in their families.
European journal of pediatrics 2008;167(4):395-9.
2008: Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joël Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.
Bulletin of the World Health Organization 2008;86(2):118-25.
2008: Julia Stowe; George Kafatos; Nick Andrews; Elizabeth Miller
Idiopathic thrombocytopenic purpura and the second dose of MMR.
Archives of disease in childhood 2008;93(2):182-3.
2008: H Lucy Thomas; Nick Andrews; Caroline Trotter; Mary Ramsay; Elizabeth Miller
Meningococcal C booster not recommended by evidence.
BMJ (Clinical research ed.) 2008;337():a1139.
2007: H Campbell; N Andrews; K E Brown; Elizabeth Miller
Review of the effect of measles vaccination on the epidemiology of SSPE.
International journal of epidemiology 2007;36(6):1334-48.
2007: Anthony Nardone; F de Ory; M Carton; D Cohen; P Van Damme; Irja Davidkin; Maria Cristina Rota; Hester E de Melker; Joël Mossong; M Slacikova; Annedore Tischer; Nick Andrews; Guy Berbers; Giovanni Gabutti; Nigel J Gay; L Jones; Sari Jokinen; George Kafatos; M V Martínez de Aragón; F Schneider; Zahava Smetana; B Vargova; Robert Vranckx; Elizabeth Miller
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.
Vaccine 2007;25(45):7866-72.
2007: Paul Balmer; Ray Borrow; Jamie Findlow; Rosalind Warrington; Sarah Frankland; Pauline Waight; Robert George; Nick Andrews; Elizabeth Miller
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.
Clinical and vaccine immunology : CVI 2007;14(11):1442-50.
2007: Alan P Johnson; Pauline Waight; Nick Andrews; Richard Pebody; Robert C George; Elizabeth Miller
Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England.
The Journal of infection 2007;55(5):394-9.
2007: Mark Jit; Andrew J Vyse; R Borrow; Richard Pebody; K Soldan; Elizabeth Miller
Prevalence of human papillomavirus antibodies in young female subjects in England.
British journal of cancer 2007;97(7):989-91.
2007: Jo Southern; Jodie McVernon; David Gelb; Nick Andrews; Rhonwen Morris; Annette Crowley-Luke; David Goldblatt; Elizabeth Miller
Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy.
Clinical and vaccine immunology : CVI 2007;14(10):1328-33.
2007: Brent Taylor; Nick Andrews; Julia Stowe; Laila Hamidi-Manesh; Elizabeth Miller
No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome.
Archives of disease in childhood 2007;92(10):887-9.
2007: Katherine N Ward; Naomi J Bryant; Nick J Andrews; Jennifer S Bowley; Anu Ohrling; Christopher M Verity; Euan M Ross; Elizabeth Miller
Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
Pediatrics 2007;120(2):314-21.
2007: Caroline Trotter; Jamie Findlow; Paul Balmer; Ann Holland; Rita Barchha; Nick Hamer; Nick Andrews; Elizabeth Miller; Ray Borrow
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
Clinical and vaccine immunology : CVI 2007;14(7):863-8.
2007: Annedore Tischer; Nick Andrews; George Kafatos; Anthony Nardone; Guy Berbers; Irja Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; Louise M Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; Fernando de Ory; K Prosenc; F Schneider; Athanassios Tsakris; M Smelhausova; Robert Vranckx; M Zarvou; Elizabeth Miller
Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.
Epidemiology and infection 2007;135(5):787-97.
2007: George Kafatos; Cleo G Anastassopoulou; Anthony Nardone; Nick Andrews; C Barbara; H J Boot; D Butur; Irja Davidkin; D Gelb; A Griskevicius; Louise M Hesketh; G Icardi; L Jones; Z Kra-Oz; Elizabeth Miller; Joël Mossong; V Nemecek; F de Ory; Z Sobotová; W Thierfelder; P Van Damme; Angelos Hatzakis
The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
Journal of viral hepatitis 2007;14(4):260-8.
2007: Elizabeth Miller; Nick Andrews; Julia Stowe; A Grant; Pauline Waight; Brent Taylor
Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
American journal of epidemiology 2007;165(6):704-9.
2007: Nick Andrews; Julia Stowe; Elizabeth Miller; Brent Taylor
Post-licensure safety of the meningococcal group C conjugate vaccine.
Human vaccines 2007;3(2):59-63.
2007: N R E Kitchin; Jo Southern; Rhonwen Morris; Fabienne Hemme; S Thomas; M W Watson; Keith Cartwright; Elizabeth Miller
Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age.
Archives of disease in childhood 2007;92(1):11-6.
2006: Cressida Auckland; Stephen Gray; Ray Borrow; Nick Andrews; David Goldblatt; Mary Ramsay; Elizabeth Miller
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom.
The Journal of infectious diseases 2006;194(12):1745-52.
2006: Ray Borrow; Elizabeth Miller
Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.
Expert review of vaccines 2006;5(6):851-7.
2006: Andrew J Vyse; Nigel J Gay; Louise M Hesketh; Richard Pebody; Peter Morgan-Capner; Elizabeth Miller
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century.
Epidemiology and infection 2006;134(6):1303-12.
2006: Jo Southern; David Gelb; Nick Andrews; Pauline Waight; Rhonwen Morris; Keith Cartwright; Elizabeth Miller
Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinations.
Human vaccines 2006;2(6):237-42.
2006: Karen Noakes; Richard Pebody; Usha Gungabissoon; Julia Stowe; Elizabeth Miller
Pneumococcal polysaccharide vaccine uptake in England, 1989-2003, prior to the introduction of a vaccination programme for older adults.
Journal of public health (Oxford, England) 2006;28(3):242-7.
2006: Jamie Findlow; Stephen Taylor; Audun Aase; Rachel Horton; Robert S Heyderman; Jo Southern; Nick Andrews; Rita Barchha; Ewan Harrison; Ann Lowe; Emma Boxer; Charlotte Heaton; Paul Balmer; Edward B Kaczmarski; Philipp Oster; Andrew R Gorringe; Ray Borrow; Elizabeth Miller
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
Infection and immunity 2006;74(8):4557-65.
2006: Ray Borrow; G M Carlone; Nancy E Rosenstein; M Blake; Ian M Feavers; Diana Martin; W Zollinger; J Robbins; Ingeborg S Aaberge; Dan M Granoff; Elizabeth Miller; Bonnie B Plikaytis; L van Alphen; Jan Poolman; R Rappuoli; Lisa Danzig; J Hackell; B Danve; M Caulfield; S Lambert; David S Stephens
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.
Vaccine 2006;24(24):5093-107.
2006: Fernando de Ory; José M Echevarría; George Kafatos; Cleo G Anastassopoulou; Nick Andrews; Josephine Backhouse; Guy Berbers; Blazena Bruckova; Daniel I Cohen; Hester E de Melker; Irja Davidkin; Giovanni Gabutti; Louise M Hesketh; Kari Johansen; Sari Jokinen; Lindsay Jones; Anika Linde; Elizabeth Miller; Joël Mossong; Anthony Nardone; Maria Cristina Rota; Andreas Sauerbrei; François Schneider; Zahava Smetana; Annedore Tischer; Athanassios Tsakris; Robert Vranckx
European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(2):111-8.
2006: Julia Stowe; Nick Andrews; Lesley Wise; Elizabeth Miller
Bell's palsy and parenteral inactivated influenza vaccine.
Human vaccines 2006;2(3):110-2.
2006: N R E Kitchin; Jo Southern; Rhonwen Morris; Fabienne Hemme; Keith Cartwright; Michael Watson; Elizabeth Miller
A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age.
Vaccine 2006;24(18):3964-70.
2006: Elinor Reynolds; Kenneth Barry Walker; Dorothy Xing; Jo Southern; Catpagavalli Asokanathan; Belinda M Dagg; Michael J Corbel; Elizabeth Miller
Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Vaccine 2006;24(16):3248-57.
2006: Helen Findlow; Jo Southern; Lesley Mabey; Paul Balmer; Robert S Heyderman; Cressida Auckland; Rhonwen Morris; Elizabeth Miller; Ray Borrow
Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.
Clinical and vaccine immunology : CVI 2006;13(4):507-10.
2006: David Goldblatt; Jo Southern; Lindsey Ashton; Peter Richmond; Polly Burbidge; Juliana Tasevska; Annette Crowley-Luke; Nick Andrews; Rhonwen Morris; Ray Borrow; Keith Cartwright; Elizabeth Miller
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
The Pediatric infectious disease journal 2006;25(4):312-9.
2006: Caroline L Trotter; W John Edmunds; Mary E Ramsay; Elizabeth Miller
Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales.
Human vaccines 2006;2(2):68-73.
2006: Jo Southern; Annette Crowley-Luke; Ray Borrow; Nick Andrews; Elizabeth Miller
Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine.
Vaccine 2006;24(2):215-9.
2006: Alessia Melegaro; W John Edmunds; Richard Pebody; Elizabeth Miller; Robert George
The current burden of pneumococcal disease in England and Wales.
The Journal of infection 2006;52(1):37-48.
2005: Alan P Johnson; Nicola Potz; Pauline Waight; Usha Gungabissoon; David M Livermore; Richard Pebody; Elizabeth Miller; Robert C George
Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001-2004.
The Journal of antimicrobial chemotherapy 2005;56(6):1181-2.
2005: Mahein Hussain; Alessia Melegaro; Richard Pebody; Robert George; W John Edmunds; R Talukdar; S A Martin; A Efstratiou; Elizabeth Miller
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting.
Epidemiology and infection 2005;133(5):891-8.
2005: David Goldblatt; Mahein Hussain; Nick Andrews; Lindsey Ashton; Camilla Virta; Alessia Melegaro; Richard Pebody; Robert George; Anu Soininen; John Edmunds; Nigel J Gay; Helena Kayhty; Elizabeth Miller
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study.
The Journal of infectious diseases 2005;192(3):387-93.
2005: Cressida Auckland; Alexandra Cowlishaw; Dilys Morgan; Elizabeth Miller
Reactions to small pox vaccine in naïve and previously-vaccinated individuals.
Vaccine 2005;23(32):4185-7.
2005: Katherine N Ward; N J Andrews; C M Verity; Elizabeth Miller; E M Ross
Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.
Archives of disease in childhood 2005;90(6):619-23.
2005: Jo Southern; Nick Andrews; Moya Burrage; Elizabeth Miller
Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers.
Vaccine 2005;23(29):3829-35.
2005: Martin H Slack; S Cade; David Schapira; Richard J Thwaites; Annette Crowley-Luke; Jo Southern; Ray Borrow; Elizabeth Miller
DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.
Archives of disease in childhood 2005;90(4):338-41.
2005: Ray Borrow; Paul Balmer; Elizabeth Miller
Meningococcal surrogates of protection--serum bactericidal antibody activity.
Vaccine 2005;23(17-18):2222-7.
2005: Martin H Slack; Richard J Thwaites; David Schapira; Annette Crowley-Luke; Jo Southern; Elizabeth Miller; David Goldblatt
Hib IgG persistence following early booster dose.
Archives of disease in childhood 2005;90(3):329.
2005: Elizabeth Miller; Nick Andrews; A Grant; Julia Stowe; Brent Taylor
No evidence of an association between MMR vaccine and gait disturbance.
Archives of disease in childhood 2005;90(3):292-6.
2005: Richard Pebody; Nigel J Gay; Anna Giammanco; S Baron; J F P Schellekens; Annedore Tischer; RM Olander; Nick J Andrews; W John Edmunds; H Lecoeur; Daniel Lévy-Bruhl; P A C Maple; Hester E de Melker; Anthony Nardone; Maria Cristina Rota; Stefania Salmaso; M A E Conyn-Van Spaendonck; S Swidsinski; Elizabeth Miller
The seroepidemiology of Bordetella pertussis infection in Western Europe.
Epidemiology and infection 2005;133(1):159-71.
2005: C Paddy Farrington; Elizabeth Miller
Informed choice, balance, and the MMR-autism saga.
The Lancet infectious diseases 2005;5(1):2-3; discussion 3-4.
2004: Andrew J Vyse; Nigel J Gay; Louise M Hesketh; Peter Morgan-Capner; Elizabeth Miller
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults.
Epidemiology and infection 2004;132(6):1129-34.
2004: C Miller; Nick Andrews; M Rush; H Munro; L Jin; Elizabeth Miller
The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
Archives of disease in childhood 2004;89(12):1145-8.
2004: Jo Southern; Sarah Deane; Lindsey Ashton; Ray Borrow; David Goldblatt; Nick Andrews; Paul Balmer; Rhonwen Morris; J Simon Kroll; Elizabeth Miller
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
Clinical and diagnostic laboratory immunology 2004;11(6):1100-4.
2004: Nick Andrews; Elizabeth Miller; Andrew Grant; Julia Stowe; Velda Osborne; Brent Taylor
Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Pediatrics 2004;114(3):584-91.
2004: Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.
Lancet 2004;364(9431):365-7.
2004: Marianne Morris-Cunnington; W John Edmunds; Elizabeth Miller
Immunity and exposure to hepatitis A virus in pre-adolescent children from a multi-ethnic inner city area.
Communicable disease and public health / PHLS 2004;7(2):134-7.
2004: Norman K Fry; Oceanis Tzivra; Y Ting Li; Anthony McNiff; Nivedita Doshi; P A Christopher Maple; Natasha S Crowcroft; Elizabeth Miller; Robert C George; Timothy G Harrison
Laboratory diagnosis of pertussis infections: the role of PCR and serology.
Journal of medical microbiology 2004;53(Pt 6):519-25.
2004: Martin H Slack; David Schapira; Richard J Thwaites; Moya Burrage; Jo Southern; David Goldblatt; Elizabeth Miller
Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life.
Archives of disease in childhood. Fetal and neonatal edition 2004;89(3):F269-71.
2004: Marianne Morris-Cunnington; W John Edmunds; Elizabeth Miller; David W G Brown
A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales.
American journal of epidemiology 2004;159(8):786-94.
2004: A Nardone; Elizabeth Miller
Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2004;9(4):5-7.
2004: Marianne Morris-Cunnington; David Brown; Jeanne Pimenta; Noah Jamie Robinson; Elizabeth Miller
New estimates of herpes simplex virus type 2 seroprevalence in England: 'high' but stable seroprevalence over the last decade.
Sexually transmitted diseases 2004;31(4):243-6.
2004: Anthony Nardone; Richard Pebody; P A C Maple; Nick Andrews; Nigel J Gay; Elizabeth Miller
Sero-epidemiology of Bordetella pertussis in England and Wales.
Vaccine 2004;22(9-10):1314-9.
2004: Mahein Hussain; Mark Clark; Amanda Tew; Lisa Williams; Elizabeth Miller
Upper respiratory tract carriage and transmission of pneumococci.
Nursing times 2004;100(1):36-9.
2004: Marianne Morris-Cunnington; W John Edmunds; Elizabeth Miller; David W G Brown
A novel method of oral fluid collection to monitor immunity to common viral infections.
Epidemiology and infection 2004;132(1):35-42.
2004: Martin H Slack; David Schapira; Richard J Thwaites; C Schapira; J Bamber; Moya Burrage; Jo Southern; Nick Andrews; Elizabeth Miller
Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.
Archives of disease in childhood. Fetal and neonatal edition 2004;89(1):F57-60.
2003: Ray Borrow; David Goldblatt; Adam Finn; Jo Southern; Lindsey Ashton; Nick Andrews; Gouri Lal; Christine Riley; Rukhsana Rahim; Keith Cartwright; Geraldine Allan; Elizabeth Miller
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.
Infection and immunity 2003;71(10):5549-55.
2003: Nick Andrews; Ray Borrow; Elizabeth Miller
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.
Clinical and diagnostic laboratory immunology 2003;10(5):780-6.
2003: N S Crowcroft; R Booy; T Harrison; L Spicer; J Britto; Q Mok; Paul Heath; I Murdoch; M Zambon; R George; Elizabeth Miller
Severe and unrecognised: pertussis in UK infants.
Archives of disease in childhood 2003;88(9):802-6.
2003: Paul Balmer; J North; D Baxter; Elaine Stanford; A Melegaro; Edward B Kaczmarski; Elizabeth Miller; Ray Borrow
Measurement and interpretation of pneumococcal IgG levels for clinical management.
Clinical and experimental immunology 2003;133(3):364-9.
2003: Wendy Knowles; Pam A Pipkin; Nick Andrews; Andrew J Vyse; Philip Minor; David W G Brown; Elizabeth Miller
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
Journal of medical virology 2003;71(1):115-23.
2003: Anthony Nardone; Richard Pebody; Susan Van den Hof; D Levy-Bruhl; AM Plesner; Maria Cristina Rota; Annedore Tischer; N Andrews; Guy Berbers; Pietro Crovari; W John Edmunds; Giovanni Gabutti; P Saliou; Elizabeth Miller
Sero-epidemiology of mumps in western Europe.
Epidemiology and infection 2003;131(1):691-701.
2003: Raghu Lingam; Andrea Simmons; Nick Andrews; Elizabeth Miller; Julia Stowe; Brent Taylor
Prevalence of autism and parentally reported triggers in a north east London population.
Archives of disease in childhood 2003;88(8):666-70.
2003: Elizabeth Miller
Measles-mumps-rubella vaccine and the development of autism.
Seminars in pediatric infectious diseases 2003;14(3):199-206.
2003: Caroline L Trotter; Ray Borrow; Nick Andrews; Elizabeth Miller
Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era.
Vaccine 2003;21(11-12):1094-8.
2003: Elizabeth Miller; Nick Andrews; P Waight; B Taylor
Bacterial infections, immune overload, and MMR vaccine. Measles, mumps, and rubella.
Archives of disease in childhood 2003;88(3):222-3.
2003: Mary E Ramsay; Nick J Andrews; Caroline L Trotter; Edward B Kaczmarski; Elizabeth Miller
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.
BMJ (Clinical research ed.) 2003;326(7385):365-6.
2003: Thomas Verstraeten; Frank DeStefano; Robert T Chen; Elizabeth Miller
Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines.
Expert review of vaccines 2003;2(1):21-9.
2003: Paddy Farrington; Elizabeth Miller
Clinical trials.
Methods in molecular medicine 2003;87():335-52.
2002: Nick Andrews; Elizabeth Miller; Brent Taylor; Raghu Lingam; Andrea Simmons; Julia Stowe; Pauline Waight
Recall bias, MMR, and autism.
Archives of disease in childhood 2002;87(6):493-4.
2002: Ray Borrow; David Goldblatt; Nick Andrews; Jo Southern; Lindsey Ashton; Sarah Deane; Rhonwen Morris; Keith Cartwright; Elizabeth Miller
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.
The Journal of infectious diseases 2002;186(9):1353-7.
2002: W J Edmunds; M Brisson; N J Gay; Elizabeth Miller
Varicella vaccination: a double-edged sword?
Communicable disease and public health / PHLS 2002;5(3):185-6.
2002: P Balmer; R Borrow; Elizabeth Miller
Impact of meningococcal C conjugate vaccine in the UK.
Journal of medical microbiology 2002;51(9):717-22.
2002: Moya Burrage; Andrew Robinson; Ray Borrow; Nick Andrews; Jo Southern; Jamie Findlow; Sarah Martin; Carol Thornton; David Goldblatt; Michael J Corbel; Dorothea Sesardic; Keith Cartwight; Peter Richmond; Elizabeth Miller
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
Infection and immunity 2002;70(9):4946-54.
2002: Li Jin; S Beard; Rashpal Hunjan; David W G Brown; Elizabeth Miller
Characterization of measles virus strains causing SSPE: a study of 11 cases.
Journal of neurovirology 2002;8(4):335-44.
2002: Marianne C Morris; W John Edmunds; Louise M Hesketh; Andrew J Vyse; Elizabeth Miller; Peter Morgan-Capner; David W G Brown
Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales.
Journal of medical virology 2002;67(4):522-7.
2002: Emma Longworth; Ray Borrow; David Goldblatt; Paul Balmer; Maureen Dawson; Nick Andrews; Elizabeth Miller; Keith Cartwright
Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants.
Vaccine 2002;20(19-20):2592-6.
2002: M C Morris; Nigel J Gay; Louise M Hesketh; Peter Morgan-Capner; Elizabeth Miller
The changing epidemiological pattern of hepatitis A in England and Wales.
Epidemiology and infection 2002;128(3):457-63.
2002: Andrew J Vyse; Nigel J Gay; Louise M Hesketh; Nick J Andrews; B Marshall; H I J Thomas; Peter Morgan-Capner; Elizabeth Miller
The burden of Helicobacter pylori infection in England and Wales.
Epidemiology and infection 2002;128(3):411-7.
2002: Paul Balmer; Elizabeth Miller
Meningococcal disease: how to prevent and how to manage.
Current opinion in infectious diseases 2002;15(3):275-81.
2002: Marc Brisson; W John Edmunds; Nigel J Gay; Elizabeth Miller
Varicella vaccine and shingles.
JAMA : the journal of the American Medical Association 2002;287(17):2211; author reply 2211-2.
2002: Natasha S Crowcroft; N Andrews; Cleo Rooney; M Brisson; Elizabeth Miller
Deaths from pertussis are underestimated in England.
Archives of disease in childhood 2002;86(5):336-8.
2002: Marc Brisson; W John Edmunds; Nigel J Gay; Elizabeth Miller
Deaths from chickenpox. Deaths from chickenpox in adults are decreasing.
BMJ (Clinical research ed.) 2002;324(7337):609.
2002: M C Morris; W John Edmunds; Elizabeth Miller; David W G Brown
Oral fluid collection by post--a pilot study of two approaches.
Public health 2002;116(2):113-9.
2002: Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.
BMJ (Clinical research ed.) 2002;324(7334):393-6.
2002: David Goldblatt; Ray Borrow; Elizabeth Miller
Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.
The Journal of infectious diseases 2002;185(3):397-400.
2002: Richard Pebody; Nigel J Gay; Louise M Hesketh; Andrew J Vyse; Peter Morgan-Capner; D W Brown; P Litton; Elizabeth Miller
Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.
Vaccine 2002;20(7-8):1134-40.
2002: Andrew J Vyse; Nigel J Gay; J M White; Mary E Ramsay; David W G Brown; BJ Cohen; Louise M Hesketh; Peter Morgan-Capner; Elizabeth Miller
Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
Epidemiologic reviews 2002;24(2):125-36.
2002: D M Salisbury; P C L Beverley; Elizabeth Miller
Vaccine programmes and policies.
British medical bulletin 2002;62():201-11.
2002: Brent Taylor; Raghu Lingam; Andrea Simmons; Julia Stowe; Elizabeth Miller; Nick Andrews
Autism and MMR vaccination in North London; no causal relationship.
Molecular psychiatry 2002;7 Suppl 2():S7-8.
2002: Elizabeth Miller
MMR vaccine: review of benefits and risks.
The Journal of infection 2002;44(1):1-6.
2001: Martin H Slack; David Schapira; Richard J Thwaites; Moya Burrage; Jo Southern; Nick Andrews; Ray Borrow; David Goldblatt; Elizabeth Miller
Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
The Journal of infectious diseases 2001;184(12):1617-20.
2001: Elizabeth Miller; D Salisbury; M Ramsay
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.
Vaccine 2001;20 Suppl 1():S58-67.
2001: Norman K Fry; S Neal; Timothy G Harrison; Elizabeth Miller; R Matthews; Robert C George
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
Infection and immunity 2001;69(9):5520-8.
2001: H Joseph; Elizabeth Miller; M Dawson; N Andrews; I Feavers; R Borrow
Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.
The Journal of infectious diseases 2001;184(5):661-2.
2001: Ray Borrow; David Goldblatt; Nick Andrews; Peter Richmond; Jo Southern; Elizabeth Miller
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
The Journal of infectious diseases 2001;184(3):377-80.
2001: Elizabeth Miller; Pauline Waight; H Laurichesse; Nick Andrews; Carol Thornton; Dorothea Sesardic; Michael J Corbel
Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR.
Vaccine 2001;19(28-29):3904-11.
2001: C Paddy Farrington; Elizabeth Miller; B Taylor
MMR and autism: further evidence against a causal association.
Vaccine 2001;19(27):3632-5.
2001: Ray Borrow; Jo Southern; Nick Andrews; N Peake; Rukhsana Rahim; M Acuna; S Martin; Elizabeth Miller; Edward B Kaczmarski
Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls.
Vaccine 2001;19(23-24):3043-50.
2001: Hester E de Melker; Richard Pebody; W John Edmunds; Daniel Lévy-Bruhl; M Valle; Maria Cristina Rota; Stefania Salmaso; Susan Van den Hof; Guy Berbers; P Saliou; Pietro Crovari; Irja Davidkin; Giovanni Gabutti; Louise M Hesketh; Peter Morgan-Capner; AM Plesner; M Raux; A Tische; Elizabeth Miller
The seroepidemiology of measles in Western Europe.
Epidemiology and infection 2001;126(2):249-59.
2001: Peter Richmond; Ray Borrow; Jamie Findlow; Sarah Martin; Carol Thornton; Keith Cartwright; Elizabeth Miller
Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
Infection and immunity 2001;69(4):2378-82.
2001: Elizabeth Miller; Pauline Waight; C P Farrington; Nick Andrews; Julia Stowe; Brent Taylor
Idiopathic thrombocytopenic purpura and MMR vaccine.
Archives of disease in childhood 2001;84(3):227-9.
2001: Ray Borrow; Nick Andrews; David Goldblatt; Elizabeth Miller
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.
Infection and immunity 2001;69(3):1568-73.
2001: Mary E Ramsay; N Andrews; E B Kaczmarski; Elizabeth Miller
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.
Lancet 2001;357(9251):195-6.
2001: Karen L Sleeman; Kyle Knox; R George; Elizabeth Miller; Pauline Waight; David Griffiths; Androulla Efstratiou; K Broughton; Richard Mayon-White; E Richard Moxon; Derrick W Crook
Invasive pneumococcal disease in England and Wales: vaccination implications.
The Journal of infectious diseases 2001;183(2):239-246.
2001: P Farrington; Elizabeth Miller
Meningococcal vaccine trials.
Methods in molecular medicine 2001;66():371-93.
2001: Nick Andrews; Elizabeth Miller; Pauline Waight; P Farrington; N Crowcroft; Julia Stowe; Brent Taylor
Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom.
European journal of epidemiology 2001;17(8):701-6.
2001: C Paddy Farrington; Elizabeth Miller
Vaccine trials.
Molecular biotechnology 2001;17(1):43-58.
2001: Peter Richmond; Ray Borrow; David Goldblatt; Jamie Findlow; Sarah Martin; Rhonwen Morris; Keith Cartwright; Elizabeth Miller
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
The Journal of infectious diseases 2001;183(1):160-3.
2000: Ray Borrow; Helen Joseph; Nick Andrews; M Acuna; Emma Longworth; S Martin; N Peake; Rukhsana Rahim; Peter Richmond; Edward B Kaczmarski; Elizabeth Miller
Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.
Vaccine 2000;19(9-10):1129-32.
2000: Elizabeth Miller; Pauline Waight; Androulla Efstratiou; M Brisson; A Johnson; R George
Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2000;89(435):11-6.
2000: B Taylor; Elizabeth Miller; C P Farrington
Response to the MMR question.
Lancet 2000;356(9237):1273.
2000: Richard Pebody; W John Edmunds; M A E Conyn-Van Spaendonck; Patrick Olin; Guy Berbers; I Rebiere; H Lecoeur; Pietro Crovari; Irja Davidkin; Giovanni Gabutti; E Gerike; C Giordano; Louise M Hesketh; AM Plesner; M Raux; Maria Cristina Rota; Stefania Salmaso; Annedore Tischer; M Valle; Elizabeth Miller
The seroepidemiology of rubella in western Europe.
Epidemiology and infection 2000;125(2):347-57.
2000: P A C Maple; Cerys S Jones; E C Wall; A Vyseb; W John Edmunds; Nick J Andrews; Elizabeth Miller
Immunity to diphtheria and tetanus in England and Wales.
Vaccine 2000;19(2-3):167-73.
2000: Nick Andrews; Richard Pebody; Guy Berbers; C Blondeau; Pietro Crovari; Irja Davidkin; P Farrington; F Fievet-Groyne; Giovanni Gabutti; E Gerike; C Giordano; Louise M Hesketh; T Marzec; Peter Morgan-Capner; KP Osborne; A M Pleisner; M Raux; Annedore Tischer; U Ruden; M Valle; Elizabeth Miller
The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella.
Epidemiology and infection 2000;125(1):127-41.
2000: W John Edmunds; Richard Pebody; H Aggerback; S Baron; Guy Berbers; M A E Conyn-Van Spaendonck; Hans O Hallander; RM Olander; P A C Maple; H E Melker; Patrick Olin; F Fievret-Groyne; C Rota; Stefania Salmaso; Annedore Tischer; Christina von Hunolstein; Elizabeth Miller
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.
Epidemiology and infection 2000;125(1):113-25.
2000: Elizabeth Miller; DM Fleming; L A Ashworth; D A Mabbett; J E Vurdien; T S J Elliott
Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham.
Communicable disease and public health / PHLS 2000;3(2):132-4.
2000: Ray Borrow; Peter Richmond; Edward B Kaczmarski; A Iverson; S L Martin; Jamie Findlow; M Acuna; Emma Longworth; R O'Connor; J Paul; Elizabeth Miller
Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
FEMS immunology and medical microbiology 2000;28(1):79-85.
2000: N J Gay; Elizabeth Miller
Pertussis transmission in England and Wales.
Lancet 2000;355(9214):1553-4.
2000: KP Osborne; Nigel J Gay; Louise M Hesketh; Peter Morgan-Capner; Elizabeth Miller
Ten years of serological surveillance in England and Wales: methods, results, implications and action.
International journal of epidemiology 2000;29(2):362-8.
2000: Peter Richmond; Edward B Kaczmarski; Ray Borrow; Jamie Findlow; S Clark; R McCann; J Hill; M Barker; Elizabeth Miller
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
The Journal of infectious diseases 2000;181(2):761-4.
1999: N S Crowcroft; C E Roth; BJ Cohen; Elizabeth Miller
Guidance for control of parvovirus B19 infection in healthcare settings and the community.
Journal of public health medicine 1999;21(4):439-46.
1999: P G Van Buynder; D Owen; J E Vurdien; N J Andrews; R C Matthews; Elizabeth Miller
Bordetella pertussis surveillance in England and Wales: 1995-7.
Epidemiology and infection 1999;123(3):403-11.
1999: David Goldblatt; Peter Richmond; E Millard; C Thornton; Elizabeth Miller
The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
The Journal of infectious diseases 1999;180(2):538-41.
1999: B Taylor; Elizabeth Miller; C P Farrington; M C Petropoulos; I Favot-Mayaud; J Li; Pauline Waight
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.
Lancet 1999;353(9169):2026-9.
1999: Elizabeth Miller
Overview of recent clinical trials of acellular pertussis vaccines.
Biologicals : journal of the International Association of Biological Standardization 1999;27(2):79-86.
1999: Peter Richmond; Ray Borrow; Elizabeth Miller; S Clark; Francesca Sadler; A Fox; NT Begg; Rhonwen Morris; Keith Cartwright
Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.
The Journal of infectious diseases 1999;179(6):1569-72.
1999: Nigel J Gay; Louise M Hesketh; KP Osborne; C P Farrington; Peter Morgan-Capner; Elizabeth Miller
The prevalence of hepatitis B infection in adults in England and Wales.
Epidemiology and infection 1999;122(1):133-8.
1999: Elizabeth Miller; P Waight; D Mercey; J Parry; JA Newham; A Nicoll
Incidence of HIV infection in homosexual men attending a sexually transmitted disease clinic in London measured by a novel unlinked anonymous method.
AIDS (London, England) 1999;13(1):143-4.
1998: T Djuretic; M J Ryan; Elizabeth Miller; C K Fairley; D Goldblatt
Hospital admissions in children due to pneumococcal pneumonia in England.
The Journal of infection 1998;37(1):54-8.
1998: Elizabeth Miller; P Waight
Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
BMJ (Clinical research ed.) 1998;316(7146):1745.
1998: Mary E Ramsay; R Brugha; David W G Brown; BJ Cohen; Elizabeth Miller
Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991-4.
Epidemiology and infection 1998;120(3):315-9.
1998: David Goldblatt; Elizabeth Miller; N McCloskey; K Cartwright
Immunological response to conjugate vaccines in infants: follow up study.
BMJ (Clinical research ed.) 1998;316(7144):1570-1.
1998: David Goldblatt; A R Vaz; Elizabeth Miller
Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.
The Journal of infectious diseases 1998;177(4):1112-5.
1998: Elizabeth Miller
Collapse reactions after whole cell pertussis vaccination.
BMJ (Clinical research ed.) 1998;316(7135):876.
1998: Elizabeth Miller; D Goldblatt; F Cutts
Measles vaccination and inflammatory bowel disease.
Lancet 1998;351(9104):755-6.
1998: H Laurichesse; O Grimaud; Pauline Waight; A P Johnson; Robert C George; Elizabeth Miller
Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.
Communicable disease and public health / PHLS 1998;1(1):22-7.
1998: Elizabeth Miller; J Eskola
Issues about pertussis vaccines.
Lancet 1998;351(9103):677-8; author reply 678-9.
1998: Elizabeth Miller; C K Fairley; BJ Cohen; C Seng
Immediate and long term outcome of human parvovirus B19 infection in pregnancy.
British journal of obstetrics and gynaecology 1998;105(2):174-8.
1998: Eugene J Gangarosa; A M Galazka; C R Wolfe; L M Phillips; R E Gangarosa; Elizabeth Miller; Robert T Chen
Impact of anti-vaccine movements on pertussis control: the untold story.
Lancet 1998;351(9099):356-61.
1998: Elizabeth Miller; Pauline Waight; P Farrington
Safety assessment post-licensure.
Developments in biological standardization 1998;95():235-43.
1998: N Gay; Elizabeth Miller
Antenatal screening for hepatitis B.
Journal of medical screening 1998;5(1):53.
1998: M Ryan; G Murphy; Elizabeth Ryan; L Nilsson; F Shackley; L Gothefors; K Oymar; Elizabeth Miller; J Storsaeter; Kingston H G Mills
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.
Immunology 1998;93(1):1-10.
1997: Alastair M Gray; Paul Fenn; J Weinberg; Elizabeth Miller; A McGuire
An economic analysis of varicella vaccination for health care workers.
Epidemiology and infection 1997;119(2):209-20.
1997: Elizabeth Miller; Nigel J Gay
Effect of age on outcome and epidemiology of infectious diseases.
Biologicals : journal of the International Association of Biological Standardization 1997;25(2):137-42.
1997: Louise M Hesketh; A Charlett; P Farrington; Elizabeth Miller; T Forsey; Peter Morgan-Capner
An evaluation of nine commercial EIA kits for the detection of measles specific IgG.
Journal of virological methods 1997;66(1):51-9.
1997: P P Mortimer; Elizabeth Miller
Commentary: antenatal screening and targeting should be sufficient in some countries.
BMJ (Clinical research ed.) 1997;314(7086):1036-7.
1997: Louise M Hesketh; J D Rowlatt; Nigel J Gay; Peter Morgan-Capner; Elizabeth Miller
Childhood infection with hepatitis A and B viruses in England and Wales.
Communicable disease report. CDR review 1997;7(4):R60-3.
1997: Elizabeth Miller; Pauline Waight; Nigel J Gay; M Ramsay; J Vurdien; Peter Morgan-Capner; Louise M Hesketh; David Brown; Pat A Tookey; Catherine Peckham
The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
Communicable disease report. CDR review 1997;7(2):R26-32.
1997: Nigel J Gay; Elizabeth Miller; Louise M Hesketh; Peter Morgan-Capner; M Ramsay; B Cohen; David Brown
Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule.
Communicable disease report. CDR review 1997;7(2):R21-6.
1997: Nigel J Gay; M Ramsay; B Cohen; Louise M Hesketh; Peter Morgan-Capner; David Brown; Elizabeth Miller
The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
Communicable disease report. CDR review 1997;7(2):R17-21.
1997: S R Killick; J Craske; Elizabeth Miller
Midwives can help increase uptake of antenatal screening for HIV.
BMJ (Clinical research ed.) 1997;314(7073):71.
1997: Elizabeth Miller
Public health implications: United Kingdom.
Developments in biological standardization 1997;89():367-8.
1997: Elizabeth Miller; Nigel J Gay
Epidemiological determinants of pertussis.
Developments in biological standardization 1997;89():15-23.
1997: Elizabeth Miller; L A Ashworth; K Redhead; C Thornton; Pauline Waight; T Coleman
Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.
Vaccine 1997;15(1):51-60.
1996: C K Fairley; Elizabeth Miller
Varicella-zoster virus epidemiology--a changing scene?
The Journal of infectious diseases 1996;174 Suppl 3():S314-9.
1996: P A Maple; Robert C George; Elizabeth Miller; P Morgan-Capner; P Hayward
Diphtheria immunity in adults.
Lancet 1996;348(9032):964.
1996: Elizabeth Miller
Immunisation policies--successes, failures and the future.
Journal of clinical pathology 1996;49(8):620-2.
1996: C P Farrington; J Nash; Elizabeth Miller
Case series analysis of adverse reactions to vaccines: a comparative evaluation.
American journal of epidemiology 1996;143(11):1165-73.
1996: J M White; C K Fairley; D Owen; R C Matthews; Elizabeth Miller
The effect of an accelerated immunisation schedule on pertussis in England and Wales.
Communicable disease report. CDR review 1996;6(6):R86-91.
1996: David Goldblatt; C K Fairley; K Cartwright; Elizabeth Miller
Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants.
BMJ (Clinical research ed.) 1996;312(7034):817-8.
1996: N Calvert; F Cutts; R Irving; D Brown; J Marsh; Elizabeth Miller
Measles immunity and response to revaccination among secondary school children in Cumbria.
Epidemiology and infection 1996;116(1):65-70.
1996: D R Tait; K N Ward; D W Brown; Elizabeth Miller
Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella [corrected].
BMJ (Clinical research ed.) 1996;312(7023):101-2.
1995: Nigel J Gay; Elizabeth Miller
Was a measles epidemic imminent?
Communicable disease report. CDR review 1995;5(13):R204-7.
1995: C K Fairley; J S Smoleniec; O E Caul; Elizabeth Miller
Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection.
Lancet 1995;346(8986):1335-7.
1995: NT Begg; Elizabeth Miller; C K Fairley; Helen Chapel; H Griffiths; Pauline Waight; L A Ashworth
Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection.
Vaccine 1995;13(16):1547-50.
1995: Elizabeth Miller
Acellular pertussis vaccines.
Archives of disease in childhood 1995;73(5):390-1.
1995: Elizabeth Miller; M Rush; L A Ashworth; T J Coleman; J Rossini; O A Ahmed; S Lingam; Mary E Ramsay
Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry.
Vaccine 1995;13(13):1183-6.
1995: Elizabeth Miller; Pauline Waight; R S Tedder; S Sutherland; P P Mortimer; M S Shafi
Incidence of HIV infection in homosexual men in London, 1988-94.
BMJ (Clinical research ed.) 1995;311(7004):545.
1995: Nigel J Gay; Louise M Hesketh; Peter Morgan-Capner; Elizabeth Miller
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.
Epidemiology and infection 1995;115(1):139-56.
1995: J Q Nash; M Chandrakumar; C P Farrington; S Williamson; Elizabeth Miller
Feasibility study for identifying adverse events attributable to vaccination by record linkage.
Epidemiology and infection 1995;114(3):475-80.
1995: Elizabeth Miller; A Hill; P Morgan-Capner; T Forsey; M Rush
Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines.
Vaccine 1995;13(9):799-802.
1995: P Farrington; Elizabeth Miller
Measles vaccination as a risk factor for inflammatory bowel disease.
Lancet 1995;345(8961):1362.
1995: M Ryan; Elizabeth Miller; P Waight
Cytomegalovirus infection in England and Wales: 1992 and 1993.
Communicable disease report. CDR review 1995;5(5):R74-6.
1995: H R Babad; D J Nokes; N J Gay; Elizabeth Miller; P Morgan-Capner; R M Anderson
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.
Epidemiology and infection 1995;114(2):319-44.
1995: P Farrington; S Pugh; A Colville; A Flower; J Nash; P Morgan-Capner; M Rush; Elizabeth Miller
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
Lancet 1995;345(8949):567-9.
1995: Mary E Ramsay; Elizabeth Miller; L A Ashworth; T J Coleman; M Rush; Pauline Waight
Adverse events and antibody response to accelerated immunisation in term and preterm infants.
Archives of disease in childhood 1995;72(3):230-2.
1994: Elizabeth Miller; J M White; C K Fairley
Pertussis vaccination.
Lancet 1994;344(8936):1575-6.
1994: Elizabeth Miller; Pat A Tookey; Peter Morgan-Capner; Louise M Hesketh; David Brown; Pauline Waight; J Vurdien; G Jones; Catherine Peckham
Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
Communicable disease report. CDR review 1994;4(12):R146-52.
1994: M Ramsay; Nigel J Gay; Elizabeth Miller; M Rush; J White; Peter Morgan-Capner; David Brown
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign.
Communicable disease report. CDR review 1994;4(12):R141-6.
1994: D Brown; Elizabeth Miller
Facing the measles epidemic.
The Practitioner 1994;238(1544):778-81.
1994: Elizabeth Miller
The new measles campaign.
BMJ (Clinical research ed.) 1994;309(6962):1102-3.
1994: D Morse; M O'Shea; G Hamilton; N Soltanpoor; G Leece; Elizabeth Miller; D Brown
Outbreak of measles in a teenage school population: the need to immunize susceptible adolescents.
Epidemiology and infection 1994;113(2):355-65.
1994: Nigel J Gay; Louise M Hesketh; B J Cohen; M Rush; C Bates; Peter Morgan-Capner; Elizabeth Miller
Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy?
Communicable disease report. CDR review 1994;4(9):R104-7.
1994: Nigel J Gay; Peter Morgan-Capner; J Wright; C P Farrington; Elizabeth Miller
Age-specific antibody prevalence to hepatitis A in England: implications for disease control.
Epidemiology and infection 1994;113(1):113-20.
1994: N J Gay; S Valambia; Douglas Galasko; Elizabeth Miller
Selective rubella vaccination programmes: a survey of districts in England and Wales.
Communicable disease report. CDR review 1994;4(7):R77-9.
1994: Georg Enders; Elizabeth Miller; J Cradock-Watson; I Bolley; M Ridehalgh
Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases.
Lancet 1994;343(8912):1548-51.
1994: A Colville; S Pugh; Elizabeth Miller
Withdrawal of a mumps vaccine.
European journal of pediatrics 1994;153(6):467-8.
1994: N Calvert; F Cutts; Elizabeth Miller; D Brown; J Munro
Measles in secondary school children: implications for vaccination policy.
Communicable disease report. CDR review 1994;4(6):R70-3.
1994: D W Brown; M E Ramsay; A F Richards; Elizabeth Miller
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3.
BMJ (Clinical research ed.) 1994;308(6935):1015-7.
1994: Elizabeth Miller
Varicella zoster virus infection in pregnancy.
Archives of disease in childhood. Fetal and neonatal edition 1994;70(2):F157-8.
1994: Elizabeth Miller; M Rush; P Morgan-Capner; D Hutchinson; L Hindle
Immunity to diphtheria in adults in England.
BMJ (Clinical research ed.) 1994;308(6928):598.
1993: Mary E Ramsay; C P Farrington; Elizabeth Miller
Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods.
Epidemiology and infection 1993;111(1):41-8.
1993: Elizabeth Miller; M Goldacre; S Pugh; A Colville; P Farrington; A Flower; J Nash; L MacFarlane; R Tettmar
Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children.
Lancet 1993;341(8851):979-82.
1993: Elizabeth Miller; P A Waight; J E Vurdien; G Jones; Pat A Tookey; Catherine Peckham
Rubella surveillance to December 1992: second joint report from the PHLS and National Congenital Rubella Surveillance Programme.
Communicable disease report. CDR review 1993;3(3):R35-40.
1993: Elizabeth Miller; J Vardien; P Farrington
Shift in age in chickenpox.
Lancet 1993;341(8840):308-9.
1992: Elizabeth Miller; J E Vurdien; J M White
The epidemiology of pertussis in England and Wales.
Communicable disease report. CDR review 1992;2(13):R152-4.
1992: P A Waight; A M Rush; Elizabeth Miller
Surveillance of HIV infection by voluntary testing in England.
Communicable disease report. CDR review 1992;2(8):R85-90.
1992: Elizabeth Miller; D J Nokes; R M Anderson
Measles, mumps, and rubella vaccination.
BMJ (Clinical research ed.) 1992;304(6839):1440-1.
1991: Elizabeth Miller; C L Miller; S R Killick; J Craske; P A Waight
Voluntary antenatal HIV testing--results of a pilot study.
CDR (London, England : Review) 1991;1(13):R147-8.
1991: Mary E Ramsay; Elizabeth Miller; C S Peckham
Outcome of confirmed symptomatic congenital cytomegalovirus infection.
Archives of disease in childhood 1991;66(9):1068-9.
1991: P A Waight; Elizabeth Miller
Incidence of HIV infection among homosexual men.
BMJ (Clinical research ed.) 1991;303(6797):311.
1991: Elizabeth Miller
Rubella in the United Kingdom.
Epidemiology and infection 1991;107(1):31-42.
1991: Peter Morgan-Capner; Elizabeth Miller; J E Vurdien; M E Ramsay
Outcome of pregnancy after maternal reinfection with rubella.
CDR (London, England : Review) 1991;1(6):R57-9.
1991: Elizabeth Miller; P A Waight; J E Vurdien; J M White; G Jones; B H Miller; Pat A Tookey; Catherine Peckham
Rubella surveillance to december 1990: a joint report from the PHLS and National Congenital Rubella Surveillance Programme.
CDR (London, England : Review) 1991;1(4):R33-7.
1991: Elizabeth Miller; L A Ashworth; A Robinson; Pauline Waight; L I Irons
Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens.
Lancet 1991;337(8733):70-3.
1990: Elizabeth Miller; P Waight; S A Rousseau; M H Hambling; P Rushton; D Ellis; G Jones
Congenital rubella in the Asian community in Britain.
BMJ (Clinical research ed.) 1990;301(6765):1391.
1990: Jann Storsaeter; Hans O Hallander; C P Farrington; Patrick Olin; R Möllby; Elizabeth Miller
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial.
Vaccine 1990;8(5):457-61.
1990: Elizabeth Miller
Rubella reinfection.
Archives of disease in childhood 1990;65(8):820-1.
1990: NT Begg; Elizabeth Miller
Role of epidemiology in vaccine policy.
Vaccine 1990;8(3):180-9.
1990: V Meurisse; Elizabeth Miller; J Kensit
Varicella in maternity units.
Lancet 1990;335(8697):1100-1.
1989: M G Thomas; L A Ashworth; Elizabeth Miller; H P Lambert
Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
The Journal of infectious diseases 1989;160(5):838-45.
1989: Jennifer M Best; Jangu Banatvala; P Morgan-Capner; Elizabeth Miller
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection.
BMJ (Clinical research ed.) 1989;299(6702):773-5.
1989: Elizabeth Miller; J E Cradock-Watson; M K Ridehalgh
Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.
Lancet 1989;2(8659):371-3.
1989: Elizabeth Miller
Rubella infection in pregnancy: remaining problems.
British journal of obstetrics and gynaecology 1989;96(8):887-9.
1989: J E Cradock-Watson; Elizabeth Miller; M K Ridehalgh; G M Terry; L Ho-Terry
Detection of rubella virus in fetal and placental tissues and in the throats of neonates after serologically confirmed rubella in pregnancy.
Prenatal diagnosis 1989;9(2):91-6.
1989: C Miller; Elizabeth Miller; K Rowe; C Bowie; M Judd; D Walker
Surveillance of symptoms following MMR vaccine in children.
The Practitioner 1989;233(1461):69-73.
1988: Elizabeth Miller
Measles, mumps and rubella vaccine.
British journal of hospital medicine 1988;40(4):247, 249.
1988: Peter Morgan-Capner; J Wright; C L Miller; Elizabeth Miller
Surveillance of antibody to measles, mumps, and rubella by age.
BMJ (Clinical research ed.) 1988;297(6651):770-2.
1988: Paul E M Fine; J A Clarkson; Elizabeth Miller
The efficacy of pertussis vaccines under conditions of household exposure. Further analysis of the 1978-80 PHLS/ERL study in 21 area health authorities in England.
International journal of epidemiology 1988;17(3):635-42.
1988: Elizabeth Miller
Measles, mumps and rubella: present and future immunisation policy.
Public health 1988;102(4):317-21.
1988: J V Parry; C P Farrington; Keith Perry; Pauline Waight; P P Mortimer; Elizabeth Miller
Rational programme for screening travellers for antibodies to hepatitis A virus.
Lancet 1988;1(8600):1447-9.
1988: G Enders; U Nickerl-Pacher; Elizabeth Miller; J E Cradock-Watson
Outcome of confirmed periconceptional maternal rubella.
Lancet 1988;1(8600):1445-7.
1988: Elizabeth Miller; C P Farrington
The current epidemiology of pertussis in the developed world: UK and West Germany.
The Tokai journal of experimental and clinical medicine 1988;13 Suppl():97-101.
1987: C Miller; Elizabeth Miller; N Begg; P Morgan-Capner
Rubella vaccination policy: a note of reassurance.
Lancet 1987;2(8552):210.
1987: C L Miller; Elizabeth Miller; P A Waight
Rubella susceptibility and the continuing risk of infection in pregnancy.
British medical journal (Clinical research ed.) 1987;294(6582):1277-8.
1987: Elizabeth Miller; A Nicoll; S A Rousseau; P J Sequeira; M H Hambling; R W Smithells; H Holzel
Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes.
British medical journal (Clinical research ed.) 1987;294(6574):737-9.
1986: Elizabeth Miller
Progress towards a new pertussis vaccine.
British medical journal (Clinical research ed.) 1986;292(6532):1348-50.
1986: L A Ashworth; A Day; H P Lambert; S Lingham; T Lissauer; Elizabeth Miller; A Robinson; D A Rutter; M G Thomas
Local and systemic immune responses to pertussis infection and cellular and acellular vaccines.
Annali Sclavo. Collana monografica 1986;3(1-2):199-211.
1985: C L Miller; Elizabeth Miller; P J Sequeira; J E Cradock-Watson; M Longson; E C Wiseberg
Effect of selective vaccination on rubella susceptibility and infection in pregnancy.
British medical journal (Clinical research ed.) 1985;291(6506):1398-401.
1985: C L Miller; Elizabeth Miller
Rubella vaccination in the UK: time for a complete strategy.
Lancet 1985;2(8457):732.
1985: T M Pollock; Elizabeth Miller; J Y Mortimer; G Smith
Post-vaccination symptoms following DTP and DT vaccination.
Developments in biological standardization 1985;61():407-10.
1984: T M Pollock; Elizabeth Miller; J Y Mortimer; G Smith
Symptoms after primary immunisation with DTP and with DT vaccine.
Lancet 1984;2(8395):146-9.
1984: T M Pollock; Elizabeth Miller; J Lobb
Severity of whooping cough in England before and after the decline in pertussis immunisation.
Archives of disease in childhood 1984;59(2):162-5.
1983: P A Waight; T M Pollock; Elizabeth Miller; E M Coleman
Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines.
Archives of disease in childhood 1983;58(11):921-3.
1983: Elizabeth Miller; T M Pollock
Strategy for rubella vaccination.
Lancet 1983;1(8323):535.
1980: Elizabeth Miller; Barbara Jacombs; T M Pollock
Whooping-cough notifications.
Lancet 1980;1(8170):718.